View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Oct. 9 (HealthDay News) -- Daily low-dose aspirin treatment may reduce global cognitive decline in older women at high risk for cardiovascular disease, according to a study published online Oct. 3 in BMJ Open.
Silke Kern, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues analyzed data from 681 women aged 70 to 92 years, of whom 95.4 percent had a high cardiovascular risk. A five-year follow-up was completed by 489 women. The Mini Mental State Examination (MMSE), word fluency, naming ability, and memory word tests were used to measure cognition.
The researchers found that women on regular low-dose acetylsalicylic acid (ASA) declined less on MMSE at follow-up than those not on ASA. The difference in cognition was significantly more pronounced in those who had ASA at both examinations (compared with never users). The same trend was seen with the other cognitive tests. For short-term dementia risk, there were no differences between the groups.
"Our study suggests a neuroprotective effect of ASA, at least for elderly women at high cardiovascular risk," the authors write. "Longer follow-ups are needed to evaluate the long-term effect of ASA on cognitive function and dementia."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top